Published in Women's Health Weekly, April 10th, 2006
"Hepatic metastases from breast cancer signal a dismal prognosis, with a median survival of 9.5 months. Twenty breast cancer patients with liver metastases underwent hepatic resection, biopsy, or ablation between 1995 and 2004. Hormone receptor status and Her-2/neu expression of primary and metastatic tumors were correlated with overall survival," scientists in the United States reported.
"At a mean follow-up of 39 months after hepatic resection, median survival was 32 months. Patients undergoing anatomic resection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly